Premium
Forte Biosciences Inc (FBRX)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It pl... Forte Biosciences Inc is a clinical-stage biopharmaceutical company, focused on dermatology. The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.04 | -0.25 | 16 | 16.18 | 14.5 | 37404 | 15.03123824 | CS |
| 4 | -7.64 | -32.3728813559 | 23.6 | 25.97 | 13.82 | 49092 | 17.4473758 | CS |
| 12 | 11.17 | 233.194154489 | 4.79 | 28.68 | 4.44 | 640400 | 14.37970684 | CS |
| 26 | 1.96 | 14 | 14 | 28.68 | 4.11 | 316343 | 13.62186178 | CS |
| 52 | -1.875 | -10.5130361648 | 17.835 | 28.68 | 4.11 | 172913 | 13.817819 | CS |
| 156 | -21.79 | -57.7218543046 | 37.75 | 44.5 | 4.11 | 124072 | 22.1183386 | CS |
| 260 | -409.04 | -96.2447058824 | 425 | 1349.75 | 4.11 | 257477 | 194.94703821 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
